Detalhe da pesquisa
1.
Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.
Nature
; 510(7505): 407-411, 2014 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-24919154
2.
Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.
Nature
; 535(7613): 580, 2016 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27049952
3.
Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma.
J Immunol
; 188(12): 5935-43, 2012 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22611241
4.
PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans.
Blood
; 115(11): 2203-13, 2010 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-20081091
5.
Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction.
J Immunol
; 185(7): 4042-52, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20826752
6.
Does the PI3K pathway promote or antagonize regulatory T cell development and function?
Front Immunol
; 3: 244, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22912633
7.
The PI3K p110δ regulates expression of CD38 on regulatory T cells.
PLoS One
; 6(3): e17359, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21390257
8.
Requirement of bic/microRNA-155 for normal immune function.
Science
; 316(5824): 608-11, 2007 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-17463290